JP2018515130A5 - - Google Patents

Download PDF

Info

Publication number
JP2018515130A5
JP2018515130A5 JP2018505536A JP2018505536A JP2018515130A5 JP 2018515130 A5 JP2018515130 A5 JP 2018515130A5 JP 2018505536 A JP2018505536 A JP 2018505536A JP 2018505536 A JP2018505536 A JP 2018505536A JP 2018515130 A5 JP2018515130 A5 JP 2018515130A5
Authority
JP
Japan
Prior art keywords
arenavirus
use according
virus
tumor
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018505536A
Other languages
English (en)
Japanese (ja)
Other versions
JP7039037B2 (ja
JP2018515130A (ja
Filing date
Publication date
Priority claimed from DE102015207036.0A external-priority patent/DE102015207036A1/de
Application filed filed Critical
Publication of JP2018515130A publication Critical patent/JP2018515130A/ja
Publication of JP2018515130A5 publication Critical patent/JP2018515130A5/ja
Priority to JP2021088871A priority Critical patent/JP7273102B2/ja
Application granted granted Critical
Publication of JP7039037B2 publication Critical patent/JP7039037B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018505536A 2015-04-17 2016-04-15 腫瘍の治療および/または阻止において使用するためのアレナウイルス(arenaviruses)、および、(改善された)腫瘍退縮特性(tumor-regression properties)を有するアレナウイルス(arenaviruses)を産生するための方法 Active JP7039037B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021088871A JP7273102B2 (ja) 2015-04-17 2021-05-27 腫瘍の治療および/または阻止において使用するためのアレナウイルス(arenaviruses)、および、(改善された)腫瘍退縮特性(tumor-regression properties)を有するアレナウイルス(arenaviruses)を産生するための方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102015207036.0 2015-04-17
DE102015207036.0A DE102015207036A1 (de) 2015-04-17 2015-04-17 Arenaviren zur Anwendung bei der Behandlung und/oder Vorbeugung von Tumoren sowie Verfahren zur Herstellung von Arenaviren mit (verbesserten) tumorregressiven Eigenschaften
PCT/EP2016/058347 WO2016166285A1 (de) 2015-04-17 2016-04-15 Arenaviren zur anwendung bei der behandlung und/oder vorbeugung von tumoren sowie verfahren zur herstellung von arenaviren mit (verbesserten) tumorregressiven eigenschaften

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021088871A Division JP7273102B2 (ja) 2015-04-17 2021-05-27 腫瘍の治療および/または阻止において使用するためのアレナウイルス(arenaviruses)、および、(改善された)腫瘍退縮特性(tumor-regression properties)を有するアレナウイルス(arenaviruses)を産生するための方法

Publications (3)

Publication Number Publication Date
JP2018515130A JP2018515130A (ja) 2018-06-14
JP2018515130A5 true JP2018515130A5 (cg-RX-API-DMAC7.html) 2019-05-23
JP7039037B2 JP7039037B2 (ja) 2022-03-22

Family

ID=55759589

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018505536A Active JP7039037B2 (ja) 2015-04-17 2016-04-15 腫瘍の治療および/または阻止において使用するためのアレナウイルス(arenaviruses)、および、(改善された)腫瘍退縮特性(tumor-regression properties)を有するアレナウイルス(arenaviruses)を産生するための方法
JP2021088871A Active JP7273102B2 (ja) 2015-04-17 2021-05-27 腫瘍の治療および/または阻止において使用するためのアレナウイルス(arenaviruses)、および、(改善された)腫瘍退縮特性(tumor-regression properties)を有するアレナウイルス(arenaviruses)を産生するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021088871A Active JP7273102B2 (ja) 2015-04-17 2021-05-27 腫瘍の治療および/または阻止において使用するためのアレナウイルス(arenaviruses)、および、(改善された)腫瘍退縮特性(tumor-regression properties)を有するアレナウイルス(arenaviruses)を産生するための方法

Country Status (8)

Country Link
US (3) US20180117137A1 (cg-RX-API-DMAC7.html)
EP (1) EP3283104B1 (cg-RX-API-DMAC7.html)
JP (2) JP7039037B2 (cg-RX-API-DMAC7.html)
CN (1) CN108025054B (cg-RX-API-DMAC7.html)
CA (1) CA2982873A1 (cg-RX-API-DMAC7.html)
DE (1) DE102015207036A1 (cg-RX-API-DMAC7.html)
ES (1) ES3017684T3 (cg-RX-API-DMAC7.html)
WO (1) WO2016166285A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2811093T3 (es) 2014-11-13 2021-03-10 Univ Geneve Arenavirus trisegmentados como vectores de vacunas
DE102015207036A1 (de) 2015-04-17 2016-10-20 Karl Sebastian Lang Arenaviren zur Anwendung bei der Behandlung und/oder Vorbeugung von Tumoren sowie Verfahren zur Herstellung von Arenaviren mit (verbesserten) tumorregressiven Eigenschaften
HK1246183A1 (zh) 2015-06-10 2018-09-07 Hookipa Biotech Gmbh Hpv疫苗
WO2017076988A1 (en) 2015-11-04 2017-05-11 Hookipa Biotech Ag Vaccines against hepatitis b virus
EP3373959B1 (en) 2015-11-12 2022-06-29 Hookipa Biotech GmbH Arenavirus particles as cancer vaccines
CN110719788A (zh) * 2017-04-07 2020-01-21 霍欧奇帕生物科技有限公司 治疗实体瘤的沙粒病毒颗粒
DE102018215551A1 (de) * 2018-09-12 2020-03-12 Virolutions Biotech Gmbh Verfahren zur Herstellung eines antitumoralen Arenavirus sowie Arenavirusmutanten
WO2022180203A1 (en) 2021-02-26 2022-09-01 Abalos Therapeutics Gmbh New virus particles for therapeutic purposes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004034461B4 (de) 2004-07-16 2008-02-07 Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus Gentherapie solider Tumore durch retrovirale, mit Arenavirus-Glykoprotein pseudotypisierte Vektoren
US7994221B2 (en) * 2004-12-06 2011-08-09 Siga Technologies, Inc. Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
CN103993012B (zh) 2007-12-27 2023-01-10 苏黎士大学 复制缺陷型沙粒病毒载体
WO2011056993A1 (en) * 2009-11-04 2011-05-12 Yale University Compositions and methods for treating cancer with attenuated oncolytic viruses
DE102015207036A1 (de) 2015-04-17 2016-10-20 Karl Sebastian Lang Arenaviren zur Anwendung bei der Behandlung und/oder Vorbeugung von Tumoren sowie Verfahren zur Herstellung von Arenaviren mit (verbesserten) tumorregressiven Eigenschaften

Similar Documents

Publication Publication Date Title
JP7273102B2 (ja) 腫瘍の治療および/または阻止において使用するためのアレナウイルス(arenaviruses)、および、(改善された)腫瘍退縮特性(tumor-regression properties)を有するアレナウイルス(arenaviruses)を産生するための方法
Wang et al. Virus-induced hepatocellular carcinoma with special emphasis on HBV
Yoo et al. Oncolytic virus‐based immunotherapies for hepatocellular carcinoma
JP2020503009A5 (cg-RX-API-DMAC7.html)
CN118853594A (zh) 嵌合痘病毒组合物及其用途
FI3728313T3 (fi) Syövän yhdistelmähoito IAP-antagonistilla ja anti-PD-1-molekyylillä
Zhang et al. Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma
JP2019532047A5 (cg-RX-API-DMAC7.html)
JP2018522041A5 (cg-RX-API-DMAC7.html)
JP2023096009A5 (cg-RX-API-DMAC7.html)
JP2016533373A5 (cg-RX-API-DMAC7.html)
Palmer et al. 333 Targeting the apical intracellular checkpoint CISH unleashes T cell neoantigen reactivity and effector program
Jindra et al. Influenza virus vector iNS1 expressing bovine papillomavirus 1 (BPV1) antigens efficiently induces tumour regression in equine sarcoid patients
Kamath et al. Therapeutic potential of combating cancer by restoring wild-type p53 through mRNA nanodelivery
CN109311893A (zh) 含有取代环戊基的吡咯并嘧啶化合物
JP2020500907A5 (cg-RX-API-DMAC7.html)
CN115998883A (zh) Cflar的抑制剂在治疗arid1a缺失型肿瘤中的应用
JP2016505009A5 (cg-RX-API-DMAC7.html)
WO2019164451A8 (en) Cancer therapeutic targeting using mutant p53-specific sirnas
JP2016506722A5 (cg-RX-API-DMAC7.html)
US20240318147A1 (en) Recombinant oncolytic virus, and construction method therefor and use thereof
JP2024508823A5 (cg-RX-API-DMAC7.html)
WO2018201602A1 (zh) 重组溶瘤ii型单纯疱疹病毒在制备抗淋巴瘤、食道癌、乳腺癌、胰腺癌药物中的应用
US20240011036A1 (en) Prevention or treatment of wasting syndrome
Feng Advancing liver cancer immunotherapy beyond checkpoint blockade